What if you invested $1000 in PFE on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Historical Annual Returns
Over the past 20 years, Pfizer Inc. has delivered an average annual return of 6.0%. The stock peaked in 2021 with a massive +66.7% gain, while investors faced a downturn in 2023 (-41.3%). Overall, the stock finished in the green 12 times out of 20 years.
Avg Return
+6.0%
Win Rate
60%
12W - 8L
Best
+66.7%
2021
Worst
-41.3%
2023
Performance Consistency
About Pfizer Inc.
Visit Website ↗Pfizer is a world-leading biopharmaceutical company. It discovers, develops, manufactures, and markets healthcare products, including medicines and vaccines.
Key Business Segments
Primary Care
Internal medicine, vaccines, and COVID-19 products.
Specialty Care
Inflammation, immunology, rare diseases, and hospital products.
Oncology
Cancer treatments (includes Seagen acquisition).
Key Innovations
- ✓Comirnaty (COVID-19 vaccine)
- ✓Paxlovid (COVID-19 antiviral)
- ✓Lipitor (historically highest selling drug)
Historical Milestones
Founded by Charles Pfizer and Charles Erhart.
Acquired Warner-Lambert.
Acquired Seagen.